1. The biology of VSIG4: Implications for the treatment of immune-mediated inflammatory diseases and cancer
    Bei Liu et al, 2023, Cancer Letters CrossRef
  2. Epstein-Barr virus-encoded latent membrane protein 1 induces epithelial to mesenchymal transition by inducing V-set Ig domain containing 4 (VSIG4) expression via NF-kB in renal tubular epithelial HK-2 cells
    Seung-Mi Kim et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  3. Cancer Stem Cells: Emergent Nature of Tumor Emergency
    Yaroslav R. Efremov et al, 2018, Frontiers in Genetics CrossRef
  4. Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma
    Shihong Lv et al, 2022, Cancer Management and Research CrossRef
  5. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma
    Wanli Yu et al, 2018, NeuroMolecular Medicine CrossRef
  6. Rab18 interacted with V-set and immunoglobulin domain-containing 4 (VSIG4) to involve in the apoptosis of glioma and the sensitivity to temozolomide
    Kai Yang et al, 2021, Bioengineered CrossRef
  7. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients
    G.Q. Yuan et al, 2017, Cancer Biomarkers CrossRef
  8. LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p/MAP3K1 axis
    Chang-Long Bi et al, 2020, Bioscience Reports CrossRef
  9. FCGR3A Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lower-Grade Glioma
    Kai Sun et al, 2022, Journal of Oncology CrossRef
  10. The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models
    Sang Youb Han et al, 2023, Life CrossRef
  11. Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes
    Edith Yuan et al, 2022, Neuro-Oncology Advances CrossRef
  12. VSIG4 Induces Epithelial-Mesenchymal Transition of Renal Tubular Cells under High-Glucose Conditions
    Eun-Yeung Gong et al, 2020, Life CrossRef
  13. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis
    Hongbin Chang et al, 2022, Bioengineered CrossRef
  14. WITHDRAWN: Long non-coding RNA NEAT1 absorbs let-7 g-5p to induce epithelial-mesenchymal transition of colon cancer cells through upregulating BACH1
    Zhenzhen Gao et al, 2021, Digestive and Liver Disease CrossRef
  15. Identification of key genes associated with head and neck squamous cell carcinoma in the microenvironment
    Hui XIE et al, 2022, Minerva Biotechnology and Biomolecular Research CrossRef
  16. The Aged Microenvironment Influences the Tumorigenic Potential of Malignant Prostate Epithelial Cells
    Daniella Bianchi-Frias et al, 2019, Molecular Cancer Research CrossRef
  17. Connexin 43 confers chemoresistance through activating PI3K
    Kevin J. Pridham et al, 2022, Oncogenesis CrossRef
  18. Non-coding RNAs and glioma: Focus on cancer stem cells
    Ali Rajabi et al, 2022, Molecular Therapy - Oncolytics CrossRef
  19. VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
    Congying Zheng et al, 2023, Neuropsychiatric Disease and Treatment CrossRef
  20. Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
    Sang Youb Han et al, 2022, Life CrossRef
  21. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer
    Kechao Nie et al, 2020, International Immunopharmacology CrossRef
  22. Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma
    Wei-Feng Zong et al, 2022, Journal of Oncology CrossRef
  23. Verbascoside inhibits progression of glioblastoma cells by promoting Let‐7g‐5p and down‐regulating HMGA2 via Wnt/beta‐catenin signalling blockade
    Wei‐Qiang Jia et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
  24. Therapeutic modulation of V Set and Ig domain-containing 4 (VSIG4) signaling in immune and inflammatory diseases
    You Li et al, 2023, Cytotherapy CrossRef